✦ LIBER ✦

EFFICACY AND SAFETY WITH LONG-ACTING INJECTABLE RISPERIDONE IN SCHIZOPHRENIA: TWO YEARS FOLLOW UP STUDY

✍ Scribed by Miguel Vega; A. Chinchilla; D. Crespo; R. Yánez; F. Pando; E. Benítez

Book ID: 119557644
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 60 KB
Volume: 102
Category: Article
ISSN: 0920-9964
DOI: 10.1016/s0920-9964(08)70826-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety and tolerability of lon

Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder

✍ Jean-Pierre Lindenmayer; Akbar Khan; Mariëlle Eerdekens; Ilse Van Hove; Stuart K 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 443 KB

LONG-TERM TREATMENT WITH LONG-ACTING INJ

LONG-TERM TREATMENT WITH LONG-ACTING INJECTION OF RISPERIDON IN PATIENTS WITH SCHIZOPRENIA - 2-YEAR FOLLOW-UP

✍ Jozef Dragasek; Ildiko Lukacsova; Judita Sokoliova; Eva Palova 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Efficacy and safety of long-acting rispe

Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder

✍ Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; Mariëlle Eerd 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi

P.3.a.015 Study of the efficacy and safe

P.3.a.015 Study of the efficacy and safety of risperidone long acting injection in elderly schizophrenia patients

✍ Y. Inoue; H. Suzuki; M. Ootomo; S. Takeda; Y. Kawaguchi; K. Gen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

A double-blind study of paliperidone pal

A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia

✍ Gahan Pandina; Rosanne Lane; Srihari Gopal; Cristiana Gassmann-Mayer; David Houg 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 543 KB

Remission in schizophrenia: 1 year Itali

Remission in schizophrenia: 1 year Italian study with risperidone long-acting injectable (RLAI) in subjects with schizophrenia or schizoaffective disorder

✍ A. Rossi; M.M. Bernareggi; M.G. Giustra 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 42 KB